The store will not work correctly when cookies are disabled.
4-Fluoro-N-[6-(2-fluoro-3-hydroxyphenyl)pyridin-2-yl]-3-hydroxybenzamide
ID: ALA4167395
Chembl Id: CHEMBL4167395
PubChem CID: 145956159
Max Phase: Preclinical
Molecular Formula: C18H12F2N2O3
Molecular Weight: 342.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1cccc(-c2cccc(O)c2F)n1)c1ccc(F)c(O)c1
Standard InChI: InChI=1S/C18H12F2N2O3/c19-12-8-7-10(9-15(12)24)18(25)22-16-6-2-4-13(21-16)11-3-1-5-14(23)17(11)20/h1-9,23-24H,(H,21,22,25)
Standard InChI Key: WYPWQNYYSUUTPS-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.30 | Molecular Weight (Monoisotopic): 342.0816 | AlogP: 3.69 | #Rotatable Bonds: 3 |
Polar Surface Area: 82.45 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.98 | CX LogP: 4.15 | CX LogD: 3.91 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.68 | Np Likeness Score: -1.01 |
References
1. Braun F, Bertoletti N, Möller G, Adamski J, Frotscher M, Guragossian N, Madeira Gírio PA, Le Borgne M, Ettouati L, Falson P, Müller S, Vollmer G, Heine A, Klebe G, Marchais-Oberwinkler S.. (2018) Structure-based design and profiling of novel 17β-HSD14 inhibitors., 155 [PMID:29859505] [10.1016/j.ejmech.2018.05.029] |